Pascal Soriot, AstraZeneca CEO (Justin Tallis/Press Association via AP Images)

As­traZeneca makes $1B deal for Gra­cell and its cell ther­a­pies, adding to Chi­na ties

As­traZeneca will pay $1 bil­lion to buy Chi­na-US cell ther­a­py com­pa­ny Gra­cell Biotech­nolo­gies, adding to a rush of deals that have been an­nounced at the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.